Inspire Advisors’s Pfizer PFE Stock Holding History

Inspire Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$760K	Buy	+31,554	New	+$825K	0.05%	276
2021 Q1	–	Sell	-2,567	Closed	-$94K	–	541
2020 Q4	$94K	Buy	+2,567	New	+$94.2K	0.04%	136

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Inspire Advisors's PFE Position: Q2 2026 in Review

Inspire Advisors opened a new position in Pfizer (PFE) in Q2 2026: 31,554 shares worth $760K. The stake represents 0.05% of the portfolio and ranks #276 among its holdings. This is a return to the name: Inspire Advisors previously reported a position in PFE as recently as Q4 2020.

Inspire Advisors first reported a position in PFE in Q4 2020 and has held it in 2 quarters since. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Inspire Advisors held 31,554 shares of Pfizer worth $760K as of Q2 2026.
Pfizer was a new Inspire Advisors position in Q2 2026.
Pfizer made up 0.05% of Inspire Advisors's portfolio in Q2 2026, its #276 holding.
Inspire Advisors first reported a position in Pfizer in Q4 2020 and has held it in 2 quarters since.
2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.